Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.
Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Ilva K, Yli-Kerttula U, Puolakka K, Järvinen P, Hakola M, Piirainen H, Ahonen J, Pälvimäki I, Forsberg S, Koota K, Friman C. Möttönen T, et al. Among authors: nissila m. Lancet. 1999 May 8;353(9164):1568-73. doi: 10.1016/s0140-6736(98)08513-4. Lancet. 1999. PMID: 10334255 Clinical Trial.
Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
Möttönen T, Hannonen P, Korpela M, Nissilä M, Kautiainen H, Ilonen J, Laasonen L, Kaipiainen-Seppänen O, Franzen P, Helve T, Koski J, Gripenberg-Gahmberg M, Myllykangas-Luosujärvi R, Leirisalo-Repo M; FIN-RACo Trial Group. FINnish Rheumatoid Arthritis Combination therapy. Möttönen T, et al. Among authors: nissila m. Arthritis Rheum. 2002 Apr;46(4):894-8. doi: 10.1002/art.10135. Arthritis Rheum. 2002. PMID: 11953964 Free article. Clinical Trial.
Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations.
Neva MH, Kauppi MJ, Kautiainen H, Luukkainen R, Hannonen P, Leirisalo-Repo M, Nissilä M, Möttönen T; FIN-RACo Trail Group. Neva MH, et al. Among authors: nissila m. Arthritis Rheum. 2000 Nov;43(11):2397-401. doi: 10.1002/1529-0131(200011)43:11<2397::AID-ANR4>3.0.CO;2-V. Arthritis Rheum. 2000. PMID: 11083260 Free article. Clinical Trial.
Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug.
Kuuliala A, Leirisalo-Repo M, Möttönen T, Hannonen P, Nissilä M, Kautiainen H, Korpela M, Julkunen H, Hakola M, Repo H; FIN-RACo Trial Group. Kuuliala A, et al. Among authors: nissila m. Clin Exp Rheumatol. 2005 Mar-Apr;23(2):243-6. Clin Exp Rheumatol. 2005. PMID: 15895898 Clinical Trial.
Letter: HL-A 27 and rheumatoid arthritis.
Isomäki H, Nissilä M, Koota K, Martio J, Tiilikainen A. Isomäki H, et al. Among authors: nissila m. Lancet. 1974 Nov 16;2(7890):1212-3. doi: 10.1016/s0140-6736(74)90858-7. Lancet. 1974. PMID: 4139633 No abstract available.
Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics.
Anderson IF, Helve T, Hannonen P, Leirisalo-Repo M, Gilboe IM, Nissilä M, Keystone EC, Kraag GR, Bjørneboe O, Chalmers A, Dovland H, Mueller E, Richard F, Whatmough I, Schmidt AG, Kovarik JM. Anderson IF, et al. Among authors: nissila m. J Rheumatol. 1999 Mar;26(3):556-62. J Rheumatol. 1999. PMID: 10090162 Clinical Trial.
92 results